FDA Inspection 915060 — Apotex Inc.

Apotex Inc. — FEI 3001617666

The FDA completed an inspection of Apotex Inc. on March 4, 2015 in Richmond Hill. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 4, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Richmond Hill (Canada)